Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael W Deininger

Showing results (71-80 of 160) with videos related to

Pageof 16
Sort By:
Leukemia|March 29, 2018
Ongoing clonal evolution in chronic myelomonocytic leukemia on hypomethylating agents: a computational perspectiveHein Than, Yi Qiao, Xiaomeng Huang, et al.
Oncotarget|May 1, 2018
Similar expression profiles in CD34<sup>+</sup> cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinibAmi B Patel, Thoralf Lange, Anthony D Pomicter, et al.
Blood|February 10, 2006
BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate-treated patients with CMLRichard D Press, Zac Love, Ashlie A Tronnes, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2021
Trident cold atmospheric plasma blocks three cancer survival pathways to overcome therapy resistanceBo Guo, Anthony D Pomicter, Francis Li, et al.
Experimental Hematology|January 5, 2013
Biological effects of T315I-mutated BCR-ABL in an embryonic stem cell-derived hematopoiesis modelMichael Melkus, Annelise Bennaceur-Griscelli, Yannick Valogne, et al.
Blood Cancer Journal|October 14, 2024
Clonal dynamics of aggressive systemic mastocytosis on avapritinib therapyXiaomeng Huang, Anthony D Pomicter, Jonathan Ahmann, et al.
Acta Haematologica|January 7, 2021
Femoral Heads from Total Hip Arthroplasty as a Source of Adult Hematopoietic CellsAnthony D Pomicter, Phillip M Clair, Dongqing Yan, et al.
Blood|April 14, 2010
CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasmsJeffrey W Tyner, Thomas G Bumm, Jutta Deininger, et al.
Haematologica|May 2, 2016
Chronic myeloid leukemia: reminiscences and dreamsTariq I Mughal, Jerald P Radich, Michael W Deininger, et al.
Haematologica|December 1, 2020
Dasatinib response in acute myeloid leukemia is correlated with FLT3/ITD, PTPN11 mutations and a unique gene expression signatureSigal Tavor, Tali Shalit, Noa Chapal Ilani, et al.
Pageof 16

Showing results (71-80 of 160) with videos related to

Sort By:
Pageof 16
Leukemia|March 29, 2018
Ongoing clonal evolution in chronic myelomonocytic leukemia on hypomethylating agents: a computational perspectiveHein Than, Yi Qiao, Xiaomeng Huang, et al.
Oncotarget|May 1, 2018
Similar expression profiles in CD34<sup>+</sup> cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinibAmi B Patel, Thoralf Lange, Anthony D Pomicter, et al.
Blood|February 10, 2006
BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate-treated patients with CMLRichard D Press, Zac Love, Ashlie A Tronnes, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2021
Trident cold atmospheric plasma blocks three cancer survival pathways to overcome therapy resistanceBo Guo, Anthony D Pomicter, Francis Li, et al.
Experimental Hematology|January 5, 2013
Biological effects of T315I-mutated BCR-ABL in an embryonic stem cell-derived hematopoiesis modelMichael Melkus, Annelise Bennaceur-Griscelli, Yannick Valogne, et al.
Blood Cancer Journal|October 14, 2024
Clonal dynamics of aggressive systemic mastocytosis on avapritinib therapyXiaomeng Huang, Anthony D Pomicter, Jonathan Ahmann, et al.
Acta Haematologica|January 7, 2021
Femoral Heads from Total Hip Arthroplasty as a Source of Adult Hematopoietic CellsAnthony D Pomicter, Phillip M Clair, Dongqing Yan, et al.
Blood|April 14, 2010
CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasmsJeffrey W Tyner, Thomas G Bumm, Jutta Deininger, et al.
Haematologica|May 2, 2016
Chronic myeloid leukemia: reminiscences and dreamsTariq I Mughal, Jerald P Radich, Michael W Deininger, et al.
Haematologica|December 1, 2020
Dasatinib response in acute myeloid leukemia is correlated with FLT3/ITD, PTPN11 mutations and a unique gene expression signatureSigal Tavor, Tali Shalit, Noa Chapal Ilani, et al.
Pageof 16